bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 1, 2024
The
C-C
motif
chemokine
receptor
8
(CCR8)
is
a
class
A
G-protein
coupled
that
has
emerged
as
promising
therapeutic
target
in
cancer
and
autoimmune
diseases.
Although
the
structures
of
human
CCR8
complex
an
antagonist
antibody
Fab1
endogenous
agonist
ligand
CCL1
have
been
solved,
structure
ligand-free
remains
to
be
determined.
Here,
we
solved
cryo-electron
microscopy
(cryo-EM)
CCR8-Gi
absence
ligand.
Structural
analysis
comparison
revealed
our
apo
undergoes
some
conformational
change
similar
CCL1-CCR8
structure,
indicating
active
state.
In
addition,
key
residues
involved
recognition
LMD-009,
potent
nonpeptidic
agonist,
were
investigated
by
mutating
testing
calcium
flux
induced
LMD-009-CCR8
interaction.
Two
mutants
CCR8,
Y1133.32A,
E2867.39A,
showed
dramatically
decreased
ability
mediating
mobilization,
their
interaction
with
LMD-009.
These
structural
biochemical
analyses
provided
molecular
insights
into
agonism
activation
will
also
facilitate
CCR8-targeted
therapy.
Biomedicines,
Год журнала:
2025,
Номер
13(1), С. 165 - 165
Опубликована: Янв. 11, 2025
Fibromyalgia
represents
a
chronic
pain
disorder
characterized
by
musculoskeletal
pain,
fatigue,
and
cognitive
impairments.
The
exact
mechanisms
underlying
fibromyalgia
remain
undefined;
as
result,
diagnosis
treatment
present
considerable
challenges.
On
the
other
hand,
endogenous
opioid
system
is
believed
to
regulate
intensity
emotional
responses;
hence,
it
might
be
expected
play
key
role
in
enhanced
sensitivity
experienced
patients.
One
explanation
for
emergence
of
disrupted
modulation
individuals
with
significant
reduction
receptor
activity
or
an
imbalance
levels
peptides.
Further
research
essential
clarify
complex
details
this
abnormality.
This
complexity
arises
from
notion
that
improved
understanding
could
contribute
development
innovative
therapeutic
strategies
aimed
at
targeting
context
fibromyalgia.
Although
progress
being
made,
complete
these
complexities
remains
challenge.
paradigm
has
potential
revolutionize
management
fibromyalgia,
although
its
implementation
may
experience
effectiveness
approach
depends
on
multiple
factors,
but
implications
profound.
Despite
challenges
involved
transformation,
improving
patient
care
considerable,
condition
long
been
inadequately
treated.
Current Issues in Molecular Biology,
Год журнала:
2024,
Номер
46(2), С. 1607 - 1620
Опубликована: Фев. 17, 2024
Melanocortin
receptor
accessory
protein
2
(MRAP2)
is
a
membrane
that
binds
multiple
G
protein-coupled
receptors
(GPCRs)
involved
in
the
control
of
energy
homeostasis,
including
prokineticin
receptors.
These
GPCRs
are
expressed
both
centrally
and
peripherally,
their
endogenous
ligands
1
(PK1)
(PK2).
PKRs
couple
all
G-protein
subtypes,
such
as
Gαq/11,
Gαs,
Gαi,
recruit
β-arrestins
upon
PK2
stimulation,
although
interaction
between
PKR2
does
not
trigger
internalisation.
MRAP2
inhibits
anorexigenic
effect
by
binding
PKR1
PKR2.
The
aim
this
work
was
to
elucidate
role
modulating
PKR2-induced
β-arrestin-2
recruitment
β-arrestin-mediated
signalling.
This
study
could
allow
identification
new
specific
targets
for
potential
drugs
useful
treatment
various
pathologies
correlated
with
prokineticin,
particular,
obesity.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Июль 22, 2024
Cancer
refers
to
the
proliferation
and
multiplication
of
aberrant
cells
inside
human
body,
characterized
by
their
capacity
proliferate
infiltrate
various
anatomical
regions.
Numerous
biochemical
pathways
signaling
molecules
have
an
impact
on
cancer
auto
biogenesis
process.
The
regulation
crucial
cellular
processes
necessary
for
cell
survival
proliferation,
which
are
triggered
phytochemicals,
is
significantly
influenced
pathways.
These
or
components
regulated
phytochemicals.
Medicinal
plants
a
significant
reservoir
diverse
anticancer
medications
employed
in
chemotherapy.
effects
phytochemicals
mediated
several
methods,
including
induction
apoptosis,
cessation
cycle,
inhibition
kinases,
prevention
carcinogenic
substances.
This
paper
analyzes
phytochemistry
seven
prominent
plant
constituents,
namely,
alkaloids,
tannins,
flavonoids,
phenols,
steroids,
terpenoids,
saponins,
focusing
involvement
MAPK/ERK
pathway,
TNF
signaling,
death
receptors,
p53,
p38,
actin
dynamics.
Hence,
this
review
has
examined
range
encompassing
structural
characteristics
potential
mechanisms.
It
underscored
significance
plant-derived
bioactive
compounds
cancer,
utilizing
molecular
In
addition,
endeavor
also
seeks
incentivize
scientists
carry
out
clinical
trials
derived
from
plants.
Proceedings of the National Academy of Sciences,
Год журнала:
2024,
Номер
121(24)
Опубликована: Июнь 3, 2024
Cannabis
sativa
is
known
for
its
therapeutic
benefit
in
various
diseases
including
pain
relief
by
targeting
cannabinoid
receptors.
The
primary
component
of
cannabis,
Δ9-tetrahydrocannabinol
(THC),
and
other
agonists
engage
the
orthosteric
site
CB1,
activating
both
Gi
β-arrestin
signaling
pathways.
activation
diverse
pathways
could
result
on-target
side
effects
cannabis
addiction,
which
may
hinder
potential.
A
significant
challenge
pharmacology
design
a
ligand
that
can
modulate
specific
CB1.
By
leveraging
insights
from
structure–function
selectivity
relationship
(SFSR),
we
have
identified
signaling–biased
agonist-allosteric
modulators
(ago-BAMs).
Further,
two
cryoelectron
microscopy
(cryo-EM)
structures
reveal
binding
mode
ago-BAM
at
extrahelical
allosteric
Combining
mutagenesis
pharmacological
studies,
elucidated
detailed
mechanism
ago-BAM-mediated
biased
signaling.
Notably,
CB-05
demonstrated
analgesic
efficacy
with
fewer
effects,
minimal
drug
toxicity
no
addiction
mouse
models.
In
summary,
our
finding
not
only
suggests
ago-BAMs
CB1
provide
potential
nonopioid
strategy
management
but
also
sheds
light
on
BAM
identification
GPCRs.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Март 17, 2024
Abstract
β-arrestins
are
key
privileged
molecular
partners
of
G-Protein
Coupled
Receptors
(GPCRs),
triggering
not
only
their
desensitization
but
also
intracellular
signaling.
Existing
structures
point
to
a
high
conformational
plasticity
β-arrestin:GPCRs
interaction,
with
two
completely
different
orientations
between
receptor
and
β-arrestin.
The
same
set
indicates
that
the
C-edge
loop
β-arrestin
could
contribute
its
anchoring
membrane,
through
an
interaction
specific
lipids,
namely
PI(4,5)P2.
Combining
dynamics
simulations
fluorescence
spectroscopy,
we
show
1
interacts
membranes
even
in
absence
receptor,
is
enhanced
by
PI(4,5)P2
presumably
holding
into
lipid
bilayer.
This
helps
adopt
“receptor
ready”
orientation.
As
consequence,
favors
coupling
ghrelin
(GHSR).
In
addition,
can
known
extreme
when
complexed
GHSR.
Of
importance,
shifts
equilibrium
arrangements,
favoring
one
them.
Simulations
performed
on
GHSR:β-arrestin
complex
suggest
release
required
for
these
transitions
occur
distribution
around
depending
orientation
receptor-bound
arrestin.
Taken
together,
our
results
highlight
how
plays
true
third
player
role
preparing
further
receptors
modulating
once
protein:protein
formed.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 24, 2025
ABSTRACT
The
dynamic
character
of
G-protein-coupled
receptors
(GPCRs)
is
essential
in
their
functionality
as
signal
transducers.
However,
the
molecular
details
how
ligands
affect
this
conformational
repertoire
to
steer
intracellular
signaling
pathways
remain
elusive.
Here,
we
address
question
by
modeling
landscape
growth
hormone
secretagogue
receptor
(GHSR-1a),
a
prototypical
peptide-activated
class
A
GPCR,
its
apo
state
and
bound
pharmacologically
distinct
ligands.
We
present
generally
applicable
protocol
efficiently
explore
space
GHSR-1a
that
sensitive
ligand.
Combining
metadynamics
simulations
Markov
modeling,
computed
free
energy
an
agonist,
antagonist,
or
inverse
respectively.
Consistent
with
current
multi-state
model
GPCR
activity,
found
populates
multiple
metastable
states
whose
energies
transition
probabilities
change
depending
on
Furthermore,
our
models
(MSM)
have
revealed
two
intermediate
not
yet
been
described
experimental
structures
which
assume
facilitate
binding
extracellular
protein
partners,
Lastly,
MSMs
allowed
us
shed
light
differences
between
basal
agonistinduced
activation.
Our
results
are
only
compatible
previously
reported
data,
but
they
capture
equilibria
governing
activation
unprecedented
detail.
Due
applicability
all
GPCRs,
valuable
tool
for
development
pharmaceuticals
targeting
family.
Journal of Cheminformatics,
Год журнала:
2025,
Номер
17(1)
Опубликована: Янв. 29, 2025
G
protein-coupled
receptors
(GPCRs)
play
vital
roles
in
various
physiological
processes,
making
them
attractive
drug
discovery
targets.
Meanwhile,
deep
learning
techniques
have
revolutionized
by
facilitating
efficient
tools
for
expediting
the
identification
and
optimization
of
ligands.
However,
existing
models
GPCRs
often
focus
on
single-target
or
a
small
subset
employ
binary
classification,
constraining
their
applicability
high
throughput
virtual
screening.
To
address
these
issues,
we
introduce
AiGPro,
novel
multitask
model
designed
to
predict
molecule
agonists
(EC50)
antagonists
(IC50)
across
231
human
GPCRs,
it
first-in-class
solution
large-scale
GPCR
profiling.
Leveraging
multi-scale
context
aggregation
bidirectional
multi-head
cross-attention
mechanisms,
our
approach
demonstrates
that
ensemble
may
not
be
necessary
predicting
complex
states
interactions.
Through
extensive
validation
using
stratified
tenfold
cross-validation,
AiGPro
achieves
robust
performance
with
Pearson's
correlation
coefficient
0.91,
indicating
broad
generalizability.
This
breakthrough
sets
new
standard
studies,
outperforming
previous
studies.
Moreover,
multi-tasking
can
agonist
antagonist
activities
wide
range
offering
comprehensive
perspective
ligand
bioactivity
within
this
diverse
superfamily.
facilitate
easy
accessibility,
deployed
web-based
platform
access
at
https://aicadd.ssu.ac.kr/AiGPro
.
Scientific
Contribution
We
learning-based
multi-task
generalize
prediction
accurately.
The
is
implemented
user-friendly
web
server
rapid
screening
small-molecule
libraries,
GPCR-targeted
discovery.
Covering
set
targets,
delivers
robust,
scalable
advancing
GPCR-focused
therapeutic
development.
proposed
framework
incorporates
an
innovative
dual-label
strategy,
enabling
simultaneous
classification
molecules
as
agonists,
antagonists,
both.
Each
further
accompanied
confidence
score,
quantitative
measure
activity
likelihood.
advancement
moves
beyond
conventional
focusing
solely
binding
affinity,
providing
more
understanding
ligand-receptor
At
core
lies
Bi-Directional
Multi-Head
Cross-Attention
(BMCA)
module,
architecture
captures
forward
backward
contextual
embeddings
protein
features.
By
leveraging
BMCA,
effectively
integrates
structural
sequence-level
information,
ensuring
precise
representation
molecular
Results
show
highly
accurate
affinity
predictions
consistent
families.
unifying
into
single
architecture,
bridge
critical
gap
modeling.
enhances
accuracy
accelerates
workflows,
valuable